User:Natalya Boufan/Sandbox 1

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
m
Line 1: Line 1:
-
== Isocitrate dehydrogenase kinase/phosphatase ==
+
==''' Isocitrate dehydrogenase kinase/phosphatase''' ==
<StructureSection load='3eps' size='340' side='right' caption='The AMP-bound AceK structure' scene=''>
<StructureSection load='3eps' size='340' side='right' caption='The AMP-bound AceK structure' scene=''>
-
 
+
-
 
+
-
This is a default text for your page '''Natalya Boufan/Sandbox 1'''. Click above on '''edit this page''' to modify. Be careful with the &lt; and &gt; signs.
+
-
You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue.
+
== Introduction ==
== Introduction ==
'''Isocitrate dehydrogenase kinase/phosphatase (IDHK/P or AceK)''' is an E. coli enzyme which phosphorylates or dephosphorylates [http://proteopedia.org/wiki/index.php/IDH isocitrate dehydrogenase (IDH)] on a specific serine residue (<scene name='78/783138/Ser113/5'>Ser113</scene>) thus regulating its activities. This is a regulatory mechanism which enables bacteria to bypass the Krebs cycle via the glyoxylate shunt in response to nutrient availability. AceK is expressed from a single gene, aceK. Both kinase and phosphatase activities reside on the same polypeptide and share the same active sites.
'''Isocitrate dehydrogenase kinase/phosphatase (IDHK/P or AceK)''' is an E. coli enzyme which phosphorylates or dephosphorylates [http://proteopedia.org/wiki/index.php/IDH isocitrate dehydrogenase (IDH)] on a specific serine residue (<scene name='78/783138/Ser113/5'>Ser113</scene>) thus regulating its activities. This is a regulatory mechanism which enables bacteria to bypass the Krebs cycle via the glyoxylate shunt in response to nutrient availability. AceK is expressed from a single gene, aceK. Both kinase and phosphatase activities reside on the same polypeptide and share the same active sites.
-
= Structure =
+
= Structure<ref>doi:10.1038/nature09088</ref> =
The AceK structure contains two functional domains: a Kinase domain (KD) where the kinase, phosphatase and ATPase reactions occur, and a regulatory (RD) that helps form allosteric binding pockets involved in regulating the catalytic domain’s function. The <scene name='78/783138/Amp_binding/7'>AMP molecule</scene> is situated in a pocket at the interface between the KD and RD and acts as a bridge.
The AceK structure contains two functional domains: a Kinase domain (KD) where the kinase, phosphatase and ATPase reactions occur, and a regulatory (RD) that helps form allosteric binding pockets involved in regulating the catalytic domain’s function. The <scene name='78/783138/Amp_binding/7'>AMP molecule</scene> is situated in a pocket at the interface between the KD and RD and acts as a bridge.
Line 14: Line 11:
= Function =
= Function =
-
AceK monitors general metabolism by responding to the levels of a wide variety of metabolites. This ability of AceK allows the IDH phosphorylation cycle to compensate for substantial perturbations of the system. When a less preferred carbon source is available, the cell responds by phosphorylating IDH, thus inactivating IDH and activating the glyoxylate bypass. Many of the regulatory effectors are derived from the end products of the glyoxylate bypass, and represent negative feedback inhibition mechanisms.
+
AceK monitors general metabolism by responding to the levels of a wide variety of metabolites. This ability of AceK allows the IDH phosphorylation cycle to compensate for substantial perturbations of the system<ref>PMID:2557093</ref>. When a less preferred carbon source is available, the cell responds by phosphorylating IDH, thus inactivating IDH and activating the glyoxylate bypass. Many of the regulatory effectors are derived from the end products of the glyoxylate bypass, and represent negative feedback inhibition mechanisms.
Furthermore, Depletion in AMP levels signals that the cell requires energy and isocitrate will continue through the Krebs cycle with IDH dephosphorylated. AMP binds directly to AceK, activate IDH phosphatase and inhibit both IDH kinase and the intrinsic ATPase activities. An AMP-mediated conformational change exposes and shields ATP, acting as a switch between AceK kinase and phosphatase activities, and ICDH-binding induces further conformational change for AceK activation. During the activation SRL of the kinase domain recognizes the ICDH active cleft and inserts into a binding pocket formed by the ICDH dimer, yielding strict substrate specificity and triggering substrate conformational change for catalysis which allow the Ser113 residue be more accessible for AceK.
Furthermore, Depletion in AMP levels signals that the cell requires energy and isocitrate will continue through the Krebs cycle with IDH dephosphorylated. AMP binds directly to AceK, activate IDH phosphatase and inhibit both IDH kinase and the intrinsic ATPase activities. An AMP-mediated conformational change exposes and shields ATP, acting as a switch between AceK kinase and phosphatase activities, and ICDH-binding induces further conformational change for AceK activation. During the activation SRL of the kinase domain recognizes the ICDH active cleft and inserts into a binding pocket formed by the ICDH dimer, yielding strict substrate specificity and triggering substrate conformational change for catalysis which allow the Ser113 residue be more accessible for AceK.
== Active Site ==
== Active Site ==
-
A catalytic triad is present in AceK, involving residues Asp457, Asn462 and Asp475, in the ATP binding region. Asp477 and Asp475 interact with the g-phosphate of ATP, and Asp475 coordinates the ATP-liganded single magnesium ion. This signature motif is crucial for the kinase activity. Lys461 interacts with ATP and Ser113, playing a significant role in binding of the reactants and keeping them in close contact conformation. Lys336, a key residue for ATP binding, is holding ATP in proper conformation through electrostatic interactions.
+
A catalytic triad is present in AceK, involving residues Asp457, Asn462 and Asp475, in the ATP binding region <ref>doi:10.1098/rstb.2011.0426</ref>. Asp477 and Asp475 interact with the g-phosphate of ATP, and Asp475 coordinates the ATP-liganded single magnesium ion. This signature motif is crucial for the kinase activity<ref>doi:10.1038/nature09088</ref>. Lys461 interacts with ATP and Ser113, playing a significant role in binding of the reactants and keeping them in close contact conformation. Lys336, a key residue for ATP binding, is holding ATP in proper conformation through electrostatic interactions<ref>doi:10.1371/journal.pone.0072048</ref>.
-
Analysis of the structural change along with calculated reaction pathway suggests that catalytic reaction of phosphotransfer process is a dissociative mechanism. In addition, theoretical calculations and experiments suggest that a phosphatase reaction follows a general acid–base catalysis associative mechanism in a stepwise mode. It is expected that more research will be done to gain more insights.
+
Analysis of the structural change along with calculated reaction pathway suggests that catalytic reaction of phosphotransfer process is a dissociative mechanism<ref>doi:10.1371/journal.pone.0072048</ref>. In addition, theoretical calculations and experiments suggest that a phosphatase reaction follows a general acid–base catalysis associative mechanism in a stepwise mode<ref>DOI: 10.1039/c4cc05375c</ref>. It is expected that more research will be done to gain more insights.
= Relevance =
= Relevance =

Revision as of 16:37, 19 March 2018

Isocitrate dehydrogenase kinase/phosphatase

The AMP-bound AceK structure

Drag the structure with the mouse to rotate

References

  1. Zheng J, Jia Z. Structure of the bifunctional isocitrate dehydrogenase kinase/phosphatase. Nature. 2010 Jun 17;465(7300):961-5. Epub 2010 May 26. PMID:20505668 doi:10.1038/nature09088
  2. Laporte DC, Stueland CS, Ikeda TP. Isocitrate dehydrogenase kinase/phosphatase. Biochimie. 1989 Sep-Oct;71(9-10):1051-7. PMID:2557093
  3. Zheng J, Yates SP, Jia Z. Structural and mechanistic insights into the bifunctional enzyme isocitrate dehydrogenase kinase/phosphatase AceK. Philos Trans R Soc Lond B Biol Sci. 2012 Sep 19;367(1602):2656-68. doi:, 10.1098/rstb.2011.0426. PMID:22889914 doi:http://dx.doi.org/10.1098/rstb.2011.0426
  4. Zheng J, Jia Z. Structure of the bifunctional isocitrate dehydrogenase kinase/phosphatase. Nature. 2010 Jun 17;465(7300):961-5. Epub 2010 May 26. PMID:20505668 doi:10.1038/nature09088
  5. Li Q, Zheng J, Tan H, Li X, Chen G, Jia Z. Unique kinase catalytic mechanism of AceK with a single magnesium ion. PLoS One. 2013 Aug 19;8(8):e72048. doi: 10.1371/journal.pone.0072048. eCollection, 2013. PMID:23977203 doi:http://dx.doi.org/10.1371/journal.pone.0072048
  6. Li Q, Zheng J, Tan H, Li X, Chen G, Jia Z. Unique kinase catalytic mechanism of AceK with a single magnesium ion. PLoS One. 2013 Aug 19;8(8):e72048. doi: 10.1371/journal.pone.0072048. eCollection, 2013. PMID:23977203 doi:http://dx.doi.org/10.1371/journal.pone.0072048
  7. Wang S, Shen Q, Chen G, Zheng J, Tan H, Jia Z. The phosphatase mechanism of bifunctional kinase/phosphatase AceK. Chem Commun (Camb). 2014 Nov 25;50(91):14117-20. doi: 10.1039/c4cc05375c. PMID:25272278 doi:http://dx.doi.org/10.1039/c4cc05375c

Proteopedia Page Contributors and Editors (what is this?)

Natalya Boufan

Personal tools